Abstract
A wide number of laboratory tests have been used to monitor heparin therapy. Until now these tests have been variations of clotting assays. Introduction of chromogenic substrates means that a new tool is at hand for monitoring heparin therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Teien AN and Lie M. 1977. Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified anti- thrombin III. Thromb.Res. 10, 399–410.
Kierulf P. 1971. Heparin. Virkemåte, indikasjoner, administrasjon. T. norske Laegeforen 91, 2105–2108.
Denson KWE and Bonnar J. 1973. The measurement of heparin. A method based on the potentiation of anti-factor Xa. Thromb. Diath. Haemorrh. 30, 471–479.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Martinus Nijhoff Publishers bv, The Hague
About this chapter
Cite this chapter
Holm, H.A., Abildgaard, U., Laerum, F., Wolland, T. (1980). Heparin Concentration (S-2222) and Effect of Heparin Treatment (Bleeding Complications, Pulmonary Embolism and Clearing of the Thrombus). In: Lijnen, H.R., Collen, D., Verstraete, M. (eds) Synthetic Substrates in Clinical Blood Coagulation Assays. Developments in Hematology, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8910-8_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-8910-8_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8912-2
Online ISBN: 978-94-009-8910-8
eBook Packages: Springer Book Archive